Organon OGN Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 53.3%-4.7pp | 58%-1.8pp | 59.8%-3.0pp | 62.8%+0.6pp | |
| Free cash flow margin | 8.7%-3.3pp | 11.9%+2.5pp | 9.5%-1.3pp | 10.7%-20.7pp | |
| Efficiency | |||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.6×0.0× | |
| Inventory turnover | 12.9×-3.7× | 16.5×-3.0× | 19.5×-1.0× | 20.5×-3.0× | |
| Liquidity | |||||
| Current ratio | 1.8×+0.2× | 1.6×+0.1× | 1.5×0.0× | 1.6×+0.1× | |
| Quick ratio | 1.7×+0.2× | 1.5×0.0× | 1.5×0.0× | 1.5×+0.1× | |
| Cash ratio | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.3×0.0× | |
| Leverage | |||||
| Debt-to-equity | 11.7×-7.4× | 19.1×— | —— | —— | |
| Debt-to-assets | 0.7×0.0× | 0.7×-0.1× | 0.7×-0.1× | 0.8×0.0× | |
| Per Share | |||||
| Book value per share | $2.88+58.3% | $1.82+767% | -$0.27+92.2% | -$3.50+41.1% | |
| Valuation | |||||
| Market capitalization | $1.86B-51.5% | $3.84B+4.2% | $3.69B-48.1% | $7.1B-8.0% | |
| Enterprise value | $10.09B-17.3% | $12.2B+2.3% | $11.92B-23.1% | $15.51B-5.1% | |
| Price / sales | 0.3×-0.3× | 0.6×0.0× | 0.6×-0.6× | 1.2×-0.1× | |
| Price / book | 2.5×-5.7× | 8.1×— | —— | —— | |
| EV / sales | 1.6×-0.3× | 1.9×0.0× | 1.9×-0.6× | 2.5×-0.1× | |
| Free cash flow yield | 28.9%+9.0pp | 19.9%+3.8pp | 16.1%+6.7pp | 9.3%-16.3pp | |
| Dividend yield | 4.7%-3.0pp | 7.7%-0.2pp | 8%+3.9pp | 4.1%+2.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Organon's ratios come from?
- Every ratio is computed from Organon's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.